Scholarly Index
Xavier Pivot
Levi Strauss (United States); 19,681 total citations; 525 total publications; best world rank #141
Levi Strauss (United States)
19,681Total citations
525Total publications
65H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cancer Treatment and Pharmacology | Lifetime | 265 | US 148 | 99.18 |
| HER2/EGFR in Cancer Research | Lifetime | 237 | US 115 | 98.95 |
| Breast Cancer Treatment Studies | Lifetime | 345 | US 177 | 98.93 |
| Advanced Breast Cancer Therapies | Lifetime | 141 | US 69 | 98.74 |
| Biosimilars and Bioanalytical Methods | Lifetime | 228 | US 83 | 96.00 |
| Colorectal Cancer Treatments and Studies | Lifetime | 878 | US 337 | 97.54 |
| Chemotherapy-related skin toxicity | Lifetime | 245 | US 137 | 92.26 |
| Breast Cancer Treatment Studies | 2021-2025 | 446 | US 146 | 95.30 |
| HER2/EGFR in Cancer Research | 2021-2025 | 304 | US 110 | 95.16 |
| Cancer Treatment and Pharmacology | 2021-2025 | 383 | US 139 | 92.16 |
| Monoclonal and Polyclonal Antibodies Research | 2021-2025 | 832 | US 264 | 89.88 |
| Advanced Breast Cancer Therapies | 2021-2025 | 859 | US 297 | 84.85 |